Schizophrenia
Conditions
Interventions
None listed
Sponsors
Otsuka Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Patients age 18 years or older to less than 65 years (at time of informed consent) diagnosed with schizophrenia based on DSM-IV-TR diagnostic criteria -Patients who are hospitalized, or judged to required hospitalization, for acute relapse of schizophrenia at time of informed consent -Patients who are experiencing acute exacerbation of psychotic symptoms
Exclusion criteria
Exclusion criteria: -Female patients who are breastfeeding or who have a positive pregnancy test (urine) result prior to receiving investigational medicinal product -Patients presenting a first episode of schizophrenia based on the clinical judgement of the investigator -Patients who are diagnosed with a disease other than schizophrenia (schizoaffective disorder, major depressive disorder, bipolar disorder, posttraumatic stress disorder, anxiety disorder, delirium, dementia, amnesia, or other cognitive disorder) based on current DSM-IV-TR Axis I criteria, or who are diagnosed with a personality disorder (borderline, paranoid, histrionic, schizotypal, schizoid, or antisocial)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factors which influence antipsychotics responses will be explored. | — |
Countries
Japan
Contacts
Public ContactHiroko Komatsu
Otsuka Pharmaceutical, Co., Ltd New Drug Research Division
Outcome results
None listed